Imaging of the Urinary Tract |
|
|
Clinical Trial: Cranberry Juice for Treatment of Urinary Tract Infections
This study is not yet open for patient recruitment.
|
Purpose
The purpose of this study is to determine whether daily consumption of cranberry juice lessens the symptoms and prevents the recurrence of urinary tract infections (UTIs). This study will also determine whether bacteria in the rectal, vaginal, and urethral areas are associated with developing UTIs.
| Condition | Treatment or Intervention |
|---|---|
| Urinary Tract Infections | Drug: Cranberry juice |
MedlinePlus related topics: Urinary Tract Infections
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Cranberry Juice and Urinary Tract Infections
Expected Total Enrollment: 400
Participants in this study will be randomly assigned to consume either 8 ounces of cranberry juice or placebo juice twice a day for 6 months. Participants will have follow-up visits at 3 and 6 months, and whenever they experience a symptomatic episode. Urine, vaginal and rectal specimens will be taken at each visit to test for the presence of bacteria that cause urinary tract infections. Participants will complete a questionnaire at study entry, Day 3, Weeks 1 and 2, and monthly thereafter or whenever there is a recurrence of symptoms.
Eligibility
Ages Eligible for Study: 18 Years - 40 Years, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Culture-confirmed urinary tract infection at study start
Exclusion Criteria:
- Other chronic disease
- Antibiotics within 72 hours prior to study start
- Hospitalization for any reason within 2 weeks prior to study start
- Stones in urinary tract
- Plans to leave Ann Arbor within 6 months after study start
- Allergy to cranberry or cranberry compounds
- Pregnancy
Location Information
Michigan
University of Michigan, Ann Arbor, Michigan, 48109, United States
Cibele T. Barbosa-Cesnik, Principal Investigator, University of Michigan
More Information
Record last reviewed: September 2004
Last Updated: October 13, 2004
Record first received: September 30, 2004
ClinicalTrials.gov Identifier: NCT00093054
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


